Form 8-K - Current report:
SEC Accession No. 0001140361-25-029143
Filing Date
2025-08-06
Accepted
2025-08-06 16:11:00
Documents
16
Period of Report
2025-08-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20053140_8k.htm   iXBRL 8-K 40669
2 EXHIBIT 10.1 ef20053140_ex10-1.htm EX-10.1 1233171
3 EXHIBIT 99.1 ef20053140_ex99-1.htm EX-99.1 341227
7 image00001.jpg GRAPHIC 5397
8 image00002.jpg GRAPHIC 8016
  Complete submission text file 0001140361-25-029143.txt   2039457

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adma-20250805.xsd EX-101.SCH 3880
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20250805_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20250805_pre.xml EX-101.PRE 16054
18 EXTRACTED XBRL INSTANCE DOCUMENT ef20053140_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 251189658
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)